-
Something wrong with this record ?
Psychodynamic day treatment programme for patients with schizophrenia spectrum disorders: Dynamics and predictors of therapeutic change
O. Pec, P. Bob, J. Pec, A. Hrubcova,
Language English Country England, Great Britain
Document type Journal Article
PubMed
28901691
DOI
10.1111/papt.12153
Knihovny.cz E-resources
- MeSH
- Day Care, Medical MeSH
- Adult MeSH
- Outcome Assessment, Health Care * MeSH
- Quality of Life * MeSH
- Middle Aged MeSH
- Humans MeSH
- Young Adult MeSH
- Follow-Up Studies MeSH
- Psychotherapy, Psychodynamic methods MeSH
- Psychotic Disorders therapy MeSH
- Schizophrenia therapy MeSH
- Psychotherapy, Group methods MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Young Adult MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
OBJECTIVES: The purpose of this study was to test whether a psychodynamically based group psychotherapeutic programme might improve symptoms, social functions, or quality of life in patients with schizophrenia spectrum disorders and to investigate factors that might predict clinical improvement or dropouts from the programme. DESIGN: A quantitative prospective cohort study. METHODS: We have investigated 81 patients with schizophrenia spectrum disorders who participated in a 9-month psychodynamically based psychotherapeutic day programme. The patients were assessed at the beginning and end of the programme, and then at 1-year follow-up. The assessment included psychotic manifestations (HoNOS), quality of life (WHOQOL-BREF), demographic data, and daily doses of medication. 21 patients dropped out from the programme, and 46 patients succeeded in undergoing follow-up assessment. RESULTS: The psychotic manifestations (self-rating version of HoNOS) and quality of life measured with WHOQOL-BREF (domains of social relationships and environment) were significantly improved at the end of the programme and at follow-up. However, the manifestations on the version for external evaluators of HoNOS were improved only at follow-up. Years of psychiatric treatment, number of hospitalizations or suicide attempts, and experience of relationships with a partner were negatively related to clinical improvement, whereas symptom severity, current working, or study activities were related positively. CONCLUSIONS: The results show that a group psychodynamic programme may improve the clinical status and quality of life of patients with schizophrenia spectrum disorders. This type of programme is more beneficial for patients with higher pre-treatment symptom severity and the presence of working or study activities. PRACTITIONER POINTS: A psychodynamically based group programme improves the clinical status and quality of life in patients with schizophrenia spectrum disorders. Data indicate that changes on the subjective level are detectable by the end of the programme, while changes on the objective level are detectable at follow-up assessment. Symptom severity and working or study activities are positively related to the clinical improvement in this type of programme, while a high number of years in psychiatric treatment or psychiatric hospitalizations are negatively related. The doses of medication (antipsychotics or antidepressants) show no significant relationship to clinical improvement.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19013083
- 003
- CZ-PrNML
- 005
- 20190416111048.0
- 007
- ta
- 008
- 190405s2018 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/papt.12153 $2 doi
- 035 __
- $a (PubMed)28901691
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Pec, Ondrej $u Center for Neuropsychiatric Research of Traumatic Stress, Department of Psychiatry and UHSL, First Faculty of Medicine, Charles University, Prague, Czech Republic. Psychotherapeutic and Psychosomatic Clinic, ESET, Prague, Czech Republic.
- 245 10
- $a Psychodynamic day treatment programme for patients with schizophrenia spectrum disorders: Dynamics and predictors of therapeutic change / $c O. Pec, P. Bob, J. Pec, A. Hrubcova,
- 520 9_
- $a OBJECTIVES: The purpose of this study was to test whether a psychodynamically based group psychotherapeutic programme might improve symptoms, social functions, or quality of life in patients with schizophrenia spectrum disorders and to investigate factors that might predict clinical improvement or dropouts from the programme. DESIGN: A quantitative prospective cohort study. METHODS: We have investigated 81 patients with schizophrenia spectrum disorders who participated in a 9-month psychodynamically based psychotherapeutic day programme. The patients were assessed at the beginning and end of the programme, and then at 1-year follow-up. The assessment included psychotic manifestations (HoNOS), quality of life (WHOQOL-BREF), demographic data, and daily doses of medication. 21 patients dropped out from the programme, and 46 patients succeeded in undergoing follow-up assessment. RESULTS: The psychotic manifestations (self-rating version of HoNOS) and quality of life measured with WHOQOL-BREF (domains of social relationships and environment) were significantly improved at the end of the programme and at follow-up. However, the manifestations on the version for external evaluators of HoNOS were improved only at follow-up. Years of psychiatric treatment, number of hospitalizations or suicide attempts, and experience of relationships with a partner were negatively related to clinical improvement, whereas symptom severity, current working, or study activities were related positively. CONCLUSIONS: The results show that a group psychodynamic programme may improve the clinical status and quality of life of patients with schizophrenia spectrum disorders. This type of programme is more beneficial for patients with higher pre-treatment symptom severity and the presence of working or study activities. PRACTITIONER POINTS: A psychodynamically based group programme improves the clinical status and quality of life in patients with schizophrenia spectrum disorders. Data indicate that changes on the subjective level are detectable by the end of the programme, while changes on the objective level are detectable at follow-up assessment. Symptom severity and working or study activities are positively related to the clinical improvement in this type of programme, while a high number of years in psychiatric treatment or psychiatric hospitalizations are negatively related. The doses of medication (antipsychotics or antidepressants) show no significant relationship to clinical improvement.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a denní péče o pacienty $7 D003631
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a hodnocení výsledků zdravotní péče $7 D017063
- 650 _2
- $a skupinová psychoterapie $x metody $7 D011615
- 650 _2
- $a psychodynamická psychoterapie $x metody $7 D064889
- 650 _2
- $a psychotické poruchy $x terapie $7 D011618
- 650 12
- $a kvalita života $7 D011788
- 650 _2
- $a schizofrenie $x terapie $7 D012559
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Bob, Petr $u Center for Neuropsychiatric Research of Traumatic Stress, Department of Psychiatry and UHSL, First Faculty of Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a Pec, Jan $u Psychotherapeutic and Psychosomatic Clinic, ESET, Prague, Czech Republic.
- 700 1_
- $a Hrubcova, Adela $u Psychotherapeutic and Psychosomatic Clinic, ESET, Prague, Czech Republic.
- 773 0_
- $w MED00012622 $t Psychology and psychotherapy $x 2044-8341 $g Roč. 91, č. 2 (2018), s. 157-168
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28901691 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190405 $b ABA008
- 991 __
- $a 20190416111113 $b ABA008
- 999 __
- $a ok $b bmc $g 1392393 $s 1051388
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 91 $c 2 $d 157-168 $e 20170913 $i 2044-8341 $m Psychology and psychotherapy $n Psychol Psychother $x MED00012622
- LZP __
- $a Pubmed-20190405